Literature DB >> 19444329

The Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas.

Zhong Chen1, Bin Yan, Carter Van Waes.   

Abstract

NF-kappaB is a family of signal activated transcription factors comprised of hetero- or homo-dimers from 5 different subunits, NF-kappaB1, NF-kappaB2, RELA, cREL and RELB. NF-kappaBs normally are transiently activated in response to infection or injury, but in cancers are aberrantly activated, regulating a transcriptome of hundreds of genes and corresponding proteome that promote pathogenesis and therapeutic resistance. In head and neck squamous cell carcinomas, an important role of NF-kappaB in regulation of the altered transcriptome and proteome has been established, providing a catalog of activating and target genes and proteins that may be useful as biomarkers of alterations in this pathway for this and other cancers. An emerging appreciation that NF-kappaB and other signal pathways form an altered regulatory network highlights the need to use biomarkers and combine targeted agents for personalized therapy of cancer.

Entities:  

Year:  2008        PMID: 19444329      PMCID: PMC2681266          DOI: 10.2217/17520363.2.4.409

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  107 in total

1.  Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.

Authors:  Tin Lap Lee; Jason Yeh; Carter Van Waes; Zhong Chen
Journal:  Mol Cancer Ther       Date:  2006-01       Impact factor: 6.261

2.  Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.

Authors:  Christine H Chung; Joel S Parker; Kim Ely; Jesse Carter; Yajun Yi; Barbara A Murphy; K Kian Ang; Adel K El-Naggar; Adam M Zanation; Anthony J Cmelak; Shawn Levy; Robbert J Slebos; Wendell G Yarbrough
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

Review 3.  Inhibitors of histone deacetylase as new anticancer agents.

Authors:  M Jung
Journal:  Curr Med Chem       Date:  2001-10       Impact factor: 4.530

4.  Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.

Authors:  John C Sok; Francesca M Coppelli; Sufi M Thomas; Miriam N Lango; Sichuan Xi; Jennifer L Hunt; Maria L Freilino; Michael W Graner; Carol J Wikstrand; Darell D Bigner; William E Gooding; Frank B Furnari; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2006-09-01       Impact factor: 12.531

5.  The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.

Authors:  Qing-Bai She; David B Solit; Qing Ye; Kathryn E O'Reilly; Jose Lobo; Neal Rosen
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

6.  Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.

Authors:  Jianming Duan; Jay Friedman; Liesl Nottingham; Zhong Chen; Gulshan Ara; Carter Van Waes
Journal:  Mol Cancer Ther       Date:  2007-01       Impact factor: 6.261

7.  Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1.

Authors:  Mark S Hipp; Carmen Urbich; Petra Mayer; Jörg Wischhusen; Michael Weller; Michael Kracht; Ioakim Spyridopoulos
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

8.  Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.

Authors:  Yun Dai; Mohamed Rahmani; Steven Grant
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

9.  Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors.

Authors:  Yin Zhang; Manfred Jung; Anatoly Dritschilo; Mira Jung
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

10.  Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma.

Authors:  Klaus Podar; Marc S Raab; Giovanni Tonon; Martin Sattler; Daniela Barilà; Jing Zhang; Yu-Tzu Tai; Hiroshi Yasui; Noopur Raje; Ronald A DePinho; Teru Hideshima; Dharminder Chauhan; Kenneth C Anderson
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

View more
  14 in total

1.  Levels of circulating soluble receptor activator of NF-κB and interleukins-1 predicting outcome of locally advanced basal cell carcinoma.

Authors:  Quan Lin; Yan Li; Duo Zhang; Hongjuan Jin
Journal:  Int J Immunopathol Pharmacol       Date:  2016-10-19       Impact factor: 3.219

2.  Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.

Authors:  Xinping Yang; Hui Cheng; Jianhong Chen; Ru Wang; Anthony Saleh; Han Si; Steven Lee; Emine Guven-Maiorov; Ozlem Keskin; Attila Gursoy; Ruth Nussinov; Jugao Fang; Carter Van Waes; Zhong Chen
Journal:  Cancer Immunol Res       Date:  2019-10-17       Impact factor: 11.151

3.  Zinc finger A20 and NF-κB correlate with high-risk human papillomavirus of squamous cell carcinoma patients.

Authors:  Ya-Juan Tang; Ahmad Taha Khalaf; Xiao-Ming Liu; Chun-Xing Xu; Wei Zhao; Sai Cheng; Ru-Zhi Zhang
Journal:  Tumour Biol       Date:  2014-09-18

4.  Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer.

Authors:  Bin Yan; Robert Vander Broek; Anthony D Saleh; Arpita Mehta; Carter Van Waes; Zhong Chen
Journal:  J Carcinog Mutagen       Date:  2013-08-05

5.  Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-κB.

Authors:  Jian Chen; Linlin Zhang; Yilai Shu; Liping Chen; Min Zhu; Song Yao; Jiabing Wang; Jianzhang Wu; Guang Liang; Haitao Wu; Wulan Li
Journal:  Biomed Res Int       Date:  2017-03-20       Impact factor: 3.411

6.  Circular RNA profiling reveals a potential role of hsa_circ_IPCEF1 in papillary thyroid carcinoma.

Authors:  Min Guo; Yushuang Sun; Junzhu Ding; Yong Li; Sihan Yang; Yanna Zhao; Xin Jin; Shan-Shan Li
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

7.  Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.

Authors:  Zoi Lanara; Efstathia Giannopoulou; Marta Fullen; Evangelos Kostantinopoulos; Jean-Christophe Nebel; Haralabos P Kalofonos; George P Patrinos; Cristiana Pavlidis
Journal:  Hum Genomics       Date:  2013-06-05       Impact factor: 4.639

8.  Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma.

Authors:  Bin Yan; Huai Li; Xinping Yang; Jiaofang Shao; Minyoung Jang; Daogang Guan; Sige Zou; Carter Van Waes; Zhong Chen; Ming Zhan
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

9.  Gene expression profile alone is inadequate in predicting complete response in multiple myeloma.

Authors:  S B Amin; W-K Yip; S Minvielle; A Broyl; Y Li; B Hanlon; D Swanson; P K Shah; P Moreau; B van der Holt; M van Duin; F Magrangeas; P Pieter Sonneveld; K C Anderson; C Li; H Avet-Loiseau; N C Munshi
Journal:  Leukemia       Date:  2014-04-15       Impact factor: 11.528

10.  Angiogenesis and evading immune destruction are the main related transcriptomic characteristics to the invasive process of oral tongue cancer.

Authors:  Juan Alberto Pérez-Valencia; Francisco Prosdocimi; Italo M Cesari; Igor Rodrigues da Costa; Carolina Furtado; Michelle Agostini; Franklin David Rumjanek
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.